Trial intelligence / Profile preview

Optimal Methotrexate With Folic Acid in Rheumatoid Arthritis

NCT04066803Phase 4Unknown

Sponsor
Sun Yat-sen University
Start
Aug 2018
Primary completion
Jul 2020
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of methotrexate, folic acid in rheumatoid arthritis (RA), sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

methotrexatefolic acid
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT04066803.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04066803.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call